Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.88 | 3.41 | 0.53 |
Stocks | 97.12 | 97.12 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.74 | 19.78 |
Price to Book | 2.89 | 3.24 |
Price to Sales | 2.49 | 2.60 |
Price to Cash Flow | 6.74 | 14.09 |
Dividend Yield | 1.29 | 1.89 |
5 Years Earnings Growth | 10.96 | 12.31 |
Name | Net % | Category Average |
---|---|---|
Industrials | 20.44 | 18.89 |
Financial Services | 19.61 | 14.83 |
Healthcare | 19.26 | 12.95 |
Technology | 12.68 | 19.26 |
Consumer Cyclical | 9.39 | 12.80 |
Communication Services | 8.08 | 5.35 |
Consumer Defensive | 5.46 | 7.08 |
Basic Materials | 5.09 | 7.20 |
Number of long holdings: 82
Number of short holdings: 6
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UCB | BE0003739530 | 3.08 | 194.50 | +1.73% | |
Argen-X | NL0010832176 | 3.00 | 641.40 | +1.97% | |
Rolls-Royce Holdings | GB00B63H8491 | 2.99 | 578.00 | +0.24% | |
Deutsche Boerse | DE0005810055 | 2.86 | 225.9000 | +1.39% | |
Compass | GB00BD6K4575 | 2.84 | 2,663.00 | +1.29% | |
London Stock Exchange | GB00B0SWJX34 | 2.80 | 11,615.0 | +1.66% | |
Partners Group | CH0024608827 | 2.80 | 1,299.00 | +2.40% | |
Chugai Pharmaceutical | JP3519400000 | 2.77 | 6,905.0 | +2.80% | |
Galderma | CH1335392721 | 2.77 | 106.54 | +0.70% | |
SAP | DE0007164600 | 2.74 | 244.750 | +0.60% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JOHCM International Select I | 4.09B | 3.41 | -4.90 | 4.48 | ||
JOHCM Emerging Markets Opps Instl | 1.08B | 6.35 | 0.28 | 3.59 | ||
JOHCM Global Equity Instl | 29.31M | 21.77 | -1.72 | 7.30 | ||
JOHCM Global Equity I | 29.31M | 21.74 | -1.79 | 7.20 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review